Pan-European trials in adjuvant colon cancer. PETACC-1: The value of Tomudex relative to standard leucovorin modulated bolus 5-fluorouracil (5-FU)

Trial Profile

Pan-European trials in adjuvant colon cancer. PETACC-1: The value of Tomudex relative to standard leucovorin modulated bolus 5-fluorouracil (5-FU)

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Aug 2008

At a glance

  • Drugs Fluorouracil; Folinic acid; Raltitrexed
  • Indications Colon cancer; Colorectal cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms PETACC-1
  • Sponsors AstraZeneca
  • Most Recent Events

    • 03 Jun 2008 Results presented at ASCO 2008 (1113588)
    • 19 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top